ChemoCentryx Inc (NASDAQ:CCXI)
| 67.93 Delayed Data As of 4:00pm ET |  +2.06 / +3.13%Today’s Change | 30.72 Today|||52-Week Range 70.29 | +9.71% Year-to-Date |
Latest CCXI News | Press Releases
No recent news for ChemoCentryx Inc.
Today’s Trading
| Previous close | 65.87 |
| Today’s open | 66.89 |
| Day’s range | 65.38 - 69.01 |
| Volume | 21,384 |
| Average volume (3 months) | 540,430 |
| Market cap | $4.7B |
Data as of 4:00pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -27.95% |
| Earnings growth (this year) | +25.36% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -15.74% |
| P/E ratio | NM |
| Price/Sales | 62.29 |
| Price/Book | 61.70 |
Competitors
| ---- | ||
| CBPOChina Biologic Produ... | -0.04 | -0.03% |
| RETAReata Pharmaceutical... | -0.93 | -0.75% |
| HCMHutchison China Medi... | -1.09 | -3.66% |
Data as of 3:59pm ET, 02/26/2021
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $36.1M |
| Annual profit (last year) | -$55.5M |
| Net profit margin | -153.59% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Mountain View, California |
Forecasts
